Confo Therapeutics Competitors and Similar CompaniesClear all

Confo Therapeutics's competitors and similar companies include Escient Pharmaceuticals, Adicet Bio, Kymera Therapeutics and Jnana.

	Confo Therapeutics Confo Therapeutics is a drug discovery company based on disruptive technology to enable the discovery of G-protein-coupled receptors (GPCR) agonists.	Escient Pharmaceuticals Escient Pharmaceuticals is a pharmaceutical company that develops therapeutics for neurosensory-inflammatory diseases.	Adicet Bio Adicet Bio is a biotechnology company that develops therapies for cancer diseases.	Kymera Therapeutics Kymera Therapeutics is a biotechnology company aimed to create medicines for patients with previously untreatable diseases.	Jnana
Founding Date	Founding Date 2015	Founding Date 2018	Founding Date 2016	Founding Date 2017	Founding Date 2017
Type	Type Private	Type Subsidiary	Type Public	Type Public	Type Private
Tags	Tags Healthcare biotech drug development therapy	Tags Healthcare biotech healthtech pharma therapy	Tags Healthcare biotech drug development therapy	Tags Healthcare biotech drug development therapy	Tags Healthcare biotech drug development therapy
Locations	Locations Elsene, BE HQ Gent, BE	Locations San Diego, US HQ	Locations Redwood City, US HQ Boston, US	Locations Watertown, US HQ Cambridge, US	Locations Boston, US HQ
Employees	Employees 761% increase	Employees 2116% decrease	Employees 1438% increase	Employees 207	Employees 891% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 116.2 m	Valuation ($) 3.1 b	Valuation ($) N/A
Financial
Net income	Net income N/A	Net income N/A	Net income ($116.8m) (FY, 2025)	Net income ($311.4m) (FY, 2025)	Net income N/A
Funding
Latest funding round	Latest funding round $ 33.5m (about 7 years ago)	Latest funding round N/A	Latest funding round N/A	Latest funding round N/A	Latest funding round $ 50m (over 8 years ago)
Total funding raised	Total funding raised $ 46m	Total funding raised $ 117.5m	Total funding raised $ 145.6m	Total funding raised $ 197m	Total funding raised $ 50m